Akero Therapeutics Inc $ 31.06 1.17 (3.91%)
Volume:
182,194
Avg Vol (1m):
288,048
Market Cap $:
1.08 Bil
Enterprise Value $:
788.46 Mil
P/E (TTM):
0.00
P/B:
3.69
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 156.33 | ||
Debt-to-Equity | 0.01 | ||
Debt-to-EBITDA | -0.03 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -41.71 | ||
ROA % | -39.27 | ||
ROC (Joel Greenblatt) % | -6424.7 |
AKRO
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 3.69 | ||
EV-to-EBIT | -11.84 | ||
EV-to-EBITDA | -11.84 | ||
Current Ratio | 24.81 | ||
Quick Ratio | 24.81 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 3.69 | ||
Earnings Yield (Greenblatt) % | -8.45 |